AR116524A1 - Potenciación de tratamiento de helmintos - Google Patents

Potenciación de tratamiento de helmintos

Info

Publication number
AR116524A1
AR116524A1 ARP190102735A ARP190102735A AR116524A1 AR 116524 A1 AR116524 A1 AR 116524A1 AR P190102735 A ARP190102735 A AR P190102735A AR P190102735 A ARP190102735 A AR P190102735A AR 116524 A1 AR116524 A1 AR 116524A1
Authority
AR
Argentina
Prior art keywords
helmintos
treatment potential
mammal
treatment
effective amount
Prior art date
Application number
ARP190102735A
Other languages
English (en)
Original Assignee
Elanco Tiergesundheit Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elanco Tiergesundheit Ag filed Critical Elanco Tiergesundheit Ag
Publication of AR116524A1 publication Critical patent/AR116524A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61D—VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
    • A61D7/00—Devices or methods for introducing solid, liquid, or gaseous remedies or other materials into or onto the bodies of animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/70—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in livestock or poultry

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La presente proporciona un método para tratar infecciones por duela hepática en un mamífero que necesita dicho tratamiento, que comprende administrar una cantidad eficaz de diamfenetida en combinación con una cantidad eficaz de clorsulón. Reivindicación 2: El método de acuerdo con la reivindicación 1, en donde el mamífero se selecciona del grupo que consiste en ovejas y ganado bovino.
ARP190102735A 2018-10-04 2019-09-26 Potenciación de tratamiento de helmintos AR116524A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201862741120P 2018-10-04 2018-10-04

Publications (1)

Publication Number Publication Date
AR116524A1 true AR116524A1 (es) 2021-05-19

Family

ID=68242870

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP190102735A AR116524A1 (es) 2018-10-04 2019-09-26 Potenciación de tratamiento de helmintos

Country Status (12)

Country Link
US (2) US11938103B2 (es)
EP (1) EP3860583A1 (es)
JP (1) JP7211683B2 (es)
CN (1) CN113194937A (es)
AR (1) AR116524A1 (es)
AU (1) AU2019355831B2 (es)
BR (1) BR112021005666A2 (es)
CA (1) CA3113830A1 (es)
MX (1) MX2021003496A (es)
RU (1) RU2766763C1 (es)
WO (1) WO2020072343A1 (es)
ZA (1) ZA202102023B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR116524A1 (es) * 2018-10-04 2021-05-19 Elanco Tiergesundheit Ag Potenciación de tratamiento de helmintos

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3896235A (en) 1970-09-01 1975-07-22 Burroughs Wellcome Co Anthelmintic ethers and composition thereof
US4064239A (en) 1974-12-16 1977-12-20 Merck & Co., Inc. Halogenated unsaturated alkyl benzenedisulfonamides as anthelmintics
LU77959A1 (es) * 1976-08-13 1978-04-27
SU697500A1 (ru) * 1977-02-14 1979-11-15 Ордена Трудового Красного Знамени Институт Медицинской Паразитологии И Тропической Медицины Им. Е.И.Марциновского Салициланилиды, обладающие антигельминтной активностью
ZA944191B (en) * 1993-06-15 1995-02-08 Univ Australian Synergistic anthelmintic compositions
EP1129713A1 (en) * 2000-02-29 2001-09-05 New Pharma Research Sweden AB Veterinary compositions for the treatment of parasitic diseases
WO2004006906A2 (en) * 2002-07-15 2004-01-22 Combinatorx, Incorporated Methods for the treatment of neoplasms
GB0501220D0 (en) * 2005-01-21 2005-03-02 Norbrook Lab Ltd Anthelmintic composition
NZ581859A (en) * 2007-06-29 2012-06-29 Pfizer Anthelmintic combination comprising 2-desoxoparaherquamide and abamectin
EP2222168B1 (en) * 2007-11-26 2018-09-12 Merial, Inc. Solvent systems for pour-on formulations for combating parasites
SG11201404595TA (en) * 2012-02-06 2014-09-26 Merial Ltd Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof
JP7032037B2 (ja) * 2013-02-27 2022-03-08 ロバート バット ローリー 経皮製剤
CN105451771B (zh) * 2013-03-15 2020-05-19 阿根塔创新有限公司 可咀嚼配制物
UY36196A (es) * 2014-07-25 2016-02-29 Bayer Animal Health Gmbh Compuestos para usar en el tratamiento antihelmíntico
AR101743A1 (es) * 2014-09-12 2017-01-11 Bayer Cropscience Ag Derivados de arilsulfuro y arilsulfóxido con uracilos unidos por c-c como agentes de control de plagas
CN107108469A (zh) * 2014-10-28 2017-08-29 拜耳动物保健有限责任公司 用于抗蠕虫治疗的化合物
WO2016118638A1 (en) * 2015-01-20 2016-07-28 Merial Inc. Anthelmintic compounds, compositions and method of using thereof
JP6899330B2 (ja) * 2015-04-02 2021-07-07 ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド 駆虫剤の組合せ及びその使用方法
US20170020848A1 (en) * 2015-04-08 2017-01-26 Merial Inc. Extended release injectable formulations comprising an isoxazoline active agent, methods and uses thereof
WO2017040763A1 (en) * 2015-09-03 2017-03-09 Agrimetis, Llc Spinosyn derivatives as insecticides
CN107868024A (zh) * 2017-10-25 2018-04-03 浙江海正药业股份有限公司 克洛索隆的晶型及其制备方法和用途
AR116524A1 (es) * 2018-10-04 2021-05-19 Elanco Tiergesundheit Ag Potenciación de tratamiento de helmintos

Also Published As

Publication number Publication date
US11938103B2 (en) 2024-03-26
MX2021003496A (es) 2021-06-23
CN113194937A (zh) 2021-07-30
US20220008366A1 (en) 2022-01-13
JP7211683B2 (ja) 2023-01-24
AU2019355831B2 (en) 2022-10-06
CA3113830A1 (en) 2020-04-09
RU2766763C1 (ru) 2022-03-15
EP3860583A1 (en) 2021-08-11
AU2019355831A1 (en) 2021-04-22
JP2022502394A (ja) 2022-01-11
WO2020072343A1 (en) 2020-04-09
BR112021005666A2 (pt) 2021-06-22
ZA202102023B (en) 2023-09-27
US20240173275A1 (en) 2024-05-30

Similar Documents

Publication Publication Date Title
CO2021000151A2 (es) Inhibidores de pd-1/pd-l1
CO2020015255A2 (es) Métodos y composiciones para tratar el cáncer
CL2020002018A1 (es) Composiciones para modular la expresión de c9orf72. (divisional solicitud 201803582)
PE20170140A1 (es) Metodos para tratar el cancer con inhibidores de tigit y agentes contra el cancer
CO2021004141A2 (es) Moduladores de la expresión de pnpla3
ECSP20081995A (es) Composiciones y métodos para el tratamiento de hemoglobinopatías y talasemias
ECSP20082339A (es) Moduladores de la expresión de apol1
CO2021002691A2 (es) Composiciones y métodos para editar el gen hidroxiácido oxidasa 1 (hao1) para tratar la hiperoxaluria primaria tipo 1 (ph1)
BR112019002458A2 (pt) composições e métodos para tratar câncer com depleção de arginina e agentes imuno-oncológicos
CO2021007006A2 (es) Moduladores de la expresión de irf5
CL2019002574A1 (es) Moduladores de la expresión de pcsk9.
BR112017000398A2 (pt) composto ou sal do mesmo, método de tratamento de uma infecção causada por dirofilaria immitis, e, kit.
CL2021002318A1 (es) Métodos de tratamiento de amiloidosis al
NI201700057A (es) Método para tratar, prevenir o reducir el riesgo de infección cutánea
CO2020008769A2 (es) Moduladores de la expresión dnm2
AR116524A1 (es) Potenciación de tratamiento de helmintos
CL2021001096A1 (es) Métodos para tratar el síndrome mielodisplásico. (divisional de la solicitud no. 202000196)
UY38472A (es) Moduladores de la expresión de foxp3
BR112019024082A2 (pt) Métodos de tratamento para distonia cervical
MX2020003554A (es) Moduladores de la expresion de enac.
CL2021003442A1 (es) Composición farmacéutica que comprende idelalisib y defactinib; y métodos para el tratamiento de cáncer.
CO2021014747A2 (es) Métodos para el tratamiento de βeta-talasemia
AR103636A1 (es) Métodos de tratamiento de neuralgia postherpética con una formulación tópica de un compuesto de espiro-oxindol
MX2018003954A (es) Metodos para mejorar la actividad de retinoides.
BR112022011836A2 (pt) Potencialização do tratamento de helmintos